Search

Search bills, members, committees and pages...

NOVOCURE INC.

15 federal lobbying filings, 2023 to 2026.

NOVOCURE INC. is a registrant on 15 federal lobbying filings, 2023 to 2026.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Clients

1 who it filed for, by filings.

ClientFilingsReported
NOVOCURE INC.15

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20262$340K
20254$440K
20244$650K
20235$670K

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
MMMMedicare/Medicaid15
VETVeterans10
TARTariff (miscellaneous tariff bills)3
TRATransportation3

Bills

The bills the filings name, by how many name them.

BillTitleFilings
S. 1717Ensuring Patient Access to Critical Breakthrough Products Act of 20255
H.R. 5343Ensuring Patient Access to Critical Breakthrough Products Act4
H.R. 1691Employee Business Expense Deduction Reinstatement Act of 20251
S. 5349DEPOTS Act1

Lobbyists

Named on the filings.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
NOVOCURE INC.NOVOCURE INC.2026 second_quarter$160KJul 19, 2026
NOVOCURE INC.NOVOCURE INC.2026 first_quarter$180KApr 20, 2026
NOVOCURE INC.NOVOCURE INC.2025 fourth_quarter$110KJan 17, 2026
NOVOCURE INC.NOVOCURE INC.2025 third_quarter$110KOct 14, 2025
NOVOCURE INC.NOVOCURE INC.2025 second_quarter$110KJul 15, 2025
NOVOCURE INC.NOVOCURE INC.2025 first_quarter$110KApr 16, 2025
NOVOCURE INC.NOVOCURE INC.2024 fourth_quarter$110KJan 14, 2025
NOVOCURE INC.NOVOCURE INC.2024 third_quarter$120KOct 15, 2024
NOVOCURE INC.NOVOCURE INC.2024 second_quarter$220KJul 22, 2024
NOVOCURE INC.NOVOCURE INC.2024 first_quarter$200KApr 22, 2024
NOVOCURE INC.NOVOCURE INC.2023 fourth_quarter$120KJan 15, 2024
NOVOCURE INC.NOVOCURE INC.2023 third_quarter$140KOct 19, 2023
NOVOCURE INC.NOVOCURE INC.2023 second_quarter$180KAug 2, 2023
NOVOCURE INC.NOVOCURE INC.2023 second_quarter$110KJul 20, 2023
NOVOCURE INC.NOVOCURE INC.2023 first_quarter$120KApr 18, 2023